Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Robert J. Kreitman, Evgeny Arons et al.|Journal of Clinical Oncology|2020Cited by 104
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Robert J. Kreitman, Liqiang Xi et al.|Blood Advances|2021Cited by 28
COVID-19 in patients with classic and variant hairy cell leukemiaRobert J. Kreitman, Evgeny Arons, Theresa Yu et al.|Blood Advances|2023Cited by 5
Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia VariantDai Chihara, Robert J. Kreitman, Evgeny Arons et al.|Blood|2019Cited by 3
Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemiaBrett Schroeder, Robert J. Kreitman, Constance M. Yuan et al.|Blood|2025Cited by 2